Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

DPHARM® Launches 2024 Event Addressing Innovation to Manage Clinical Trials Complexity, Capabilities Gaps and Costs Organized by the Conference Forum


News provided by

The Conference Forum

Jun 13, 2024, 16:30 ET

Share this article

Share toX

Share this article

Share toX


The Conference Forum announced the launch of the 14th annual DPHARM®: Disruptive Innovations to Modernize Clinical Research's agenda, with the focus on innovating to manage complexity, capabilities gaps and costs.

NEW YORK, June 13, 2024 /PRNewswire-PRWeb/ -- The Conference Forum announced today the launch of the 14th annual DPHARM: Disruptive Innovations to Modernize Clinical Research conference, taking place September 17-18, 2024, at the Loews Philadelphia Hotel in Philadelphia, PA.

The 2024 meeting offers an unparalleled opportunity to hear senior clinical operations executives and innovative thought leaders discuss innovating in resource-constrained environments, decision-making and risk management, and the latest technologies modernizing clinical trials and driving greater inclusivity and value for patients.

"DPHARM provides clinical development decision-makers with the opportunity to hear from a range of innovation thought leaders, giving them the opportunity to learn, benchmark with the best and implement disruptions within their own companies." Doug Schantz, Asklepios BioPharmaceutical, Inc

Post this

"Carefully guided by 50 clinical operations leaders, this year's DPHARM agenda gets granular on how to respond to the increasing complexity in the clinical trials landscape and strategically deploying AI and GenAI." said Tracey Kimball, DPHARM Conference Director, Conference Forum.

"The focus on exploring innovative approaches to effectively manage the complexities, bridge capability gaps, and optimize costs within the pharmaceutical industry is crucial for driving industry progress, enhancing operational efficiency, and fostering a culture of continuous improvement. At this year's meeting, industry stakeholders can gain valuable insights and strategies to navigate the evolving landscape and stay ahead in a competitive market," Angela DeLuca, MBA, PMP, VP, Head of Oncology & Cell Therapies Clinical Operations Global Development Office, R&D, Takeda.

The 2024 keynotes, featured speakers and panel discussions lead the conversation on innovating for complexity, capabilities and costs:

  • Patient Keynote with Sarah Zenner-Dolan, Patient Advocate
  • Risk and Decision-Making Keynote with Captain "Sully" Sullenberger, U.S. Airways Flight 1549 Captain, Miracle on the Hudson
  • Examining ROI from DCT Deployments Keynote, with Ken Getz, MBA, Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine
  • AI and GenAI in Drug Development with Faisal M. Khan, PhD, Corporate Vice President, AI and Analytics, Novo Nordisk
  • Aligning Innovations to Solve Clinical Trials' Big Problems in a Resource-Constrained Environment, moderated by Nick Slack, MBE, Chairman and CEO, The START Center for Cancer Research; Executive in Residence, Warburg Pincus
  • How Pharma is Shifting Operating Models for More Efficient Clinical Trials, moderated by Bari Kowal, SVP and Head, Development Operations, Portfolio Management and Biostatistics Data Management, Regeneron
  • Leadership on New Thinking to Accelerate Clinical Development, moderated by Siân Ratcliffe, PhD, SVP, Head of Quantitative Sciences and Development Operations, Biogen

Pharma-led case studies take a deep dive into innovations in the following areas:

  • Deploying AI and Automation to Drive Efficiencies, Optimize Protocol Design and Compress Trial Cycle Times
  • Driving Sustainable Growth through Strategic Collaborations and Change Management
  • Operationalizing Patient Insights in Protocol Planning and Trial Design and Scaling eSource EHRs
  • Fueling Large Scale Innovation, Organizational Ambidexterity and Workforce Diversity

"DPHARM provides clinical development decision-makers with the opportunity to hear from innovation thought leaders both within and outside of the pharmaceutical industry, giving them the opportunity to learn, benchmark with the best and implement disruptions within their own companies," Doug Schantz, SVP, Clinical Operations, Asklepios BioPharmaceutical, Inc

For the change management and AI sessions, the following organizations will be presenting at DPHARM 2024:

  • Boehringer Ingelheim
  • CSL
  • Johnson & Johnson
  • Merck
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Regeneron
  • Sanofi
  • Takeda

DPHARM will be preceded by the 11th annual Mobile Tech in Clinical Trials and the 9th annual CRAACO®: Clinical Research as a Care Option conferences, September 16, 2024. To learn more, visit http://www.theconferenceforum.org.

For the full DPHARM agenda, visit http://www.DPHARMconference.com.

About DPHARM:
DPHARM®: Disruptive Innovations to Modernize Clinical Research offers an unparalleled opportunity to hear senior clinical operation executives and innovative thought leaders unveil the latest innovations to modernize clinical trials and reduce patient burden. The concept of DPHARM was founded by Pfizer and Janssen, who continue to play a key role on the steering committee to deliver a highly relevant and engaging program. DPHARM takes place September 17-18 at the Loews Philadelphia Hotel in Philadelphia, PA where its inaugural meeting took place.

About The Conference Forum:
The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. The company also publishes digital editorial across six categories, and produces PharmaTalkRadio, virtual events, and webinars.

Media Contact

Denise Adrian, The Conference Forum, (646) 350-2580, [email protected], http://www.theconferenceforum.org 

SOURCE The Conference Forum

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.